First reported case of safe and efficacious use of tocilizumab for treatment of hyperinflammatory syndrome associated with COVID-19 in an allogeneic stem cell transplant patient.

Fordham, Nicholas; Baker, Emma; Forton, Daniel; Klammer, Matthias; Patel, Kamal; Qadir, Dara; Reyal, Yasmin; Willis, Fenella; Koh, Mickey B C

Fordham, Nicholas; Baker, Emma; Forton, Daniel; Klammer, Matthias; Patel, Kamal; Qadir, Dara; Reyal, Yasmin; Willis, Fenella; Koh, Mickey B C.

Afiliação

Fordham N; Haematology Department St George's University Hospitals NHS Foundation Trust London UK.
Baker E; St Catherine's College University of Oxford Oxford UK.
Forton D; Institute of Infection and Immunity St George's University of London UK.
Klammer M; Department of Gastroenterology and Hepatology St George's University Hospitals NHS Foundation Trust London UK.
Patel K; Haematology Department St George's University Hospitals NHS Foundation Trust London UK.
Qadir D; Department of Gastroenterology and Hepatology St George's University Hospitals NHS Foundation Trust London UK.
Reyal Y; Haematology Department St George's University Hospitals NHS Foundation Trust London UK.
Willis F; Haematology Department St George's University Hospitals NHS Foundation Trust London UK.
Koh MBC; Haematology Department St George's University Hospitals NHS Foundation Trust London UK.

EJHaem ; 2(1): 143-146, 2021 Feb.

Article em En | MEDLINE | ID: mdl-35846103

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article